Oval cell hyperplasia in asparaginase--induced liver damage.
Zuckerman
E
E
Misselevich
I
I
Boss
J H
JH
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001215:Asparaginase / Q000009:adverse effects*; D017809:Fatal Outcome; D005234:Fatty Liver / Q000209:etiology* / Q000473:pathology; D005260:Female; D022781:Hepatocytes / Q000187:drug effects / Q000473:pathology; D006801:Humans; D006965:Hyperplasia / Q000473:pathology; D009102:Multiple Organ Failure / Q000150:complications / Q000473:pathology; D009767:Obesity, Morbid / Q000150:complications / Q000473:pathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D013234:Stem Cells / Q000187:drug effects / Q000473:pathology
D001215:Asparaginase